Metastatic placental site trophoblastic tumor. Report of a case with complete response to chemotherapy

J Reprod Med. 2001 Mar;46(3):259-62.

Abstract

Background: Placental site trophoblastic tumor (PSTT) is a rare form of gestational trophoblastic neoplasia, commonly insensitive to chemotherapeutic agents.

Case: We report on long-term remission in a patient with metastatic PSTT after etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine combination chemotherapy. The 27-year-old patient with metastatic lung PSTT was alive, without evidence of disease, > 40 months after treatment.

Conclusion: Treatment with multiagent chemotherapy can produce long-term remission, even in patients with metastatic PSTT.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cyclophosphamide / therapeutic use
  • Dactinomycin / therapeutic use
  • Etoposide / therapeutic use
  • Female
  • Humans
  • Lung Neoplasms / secondary
  • Methotrexate / therapeutic use
  • Pregnancy
  • Remission Induction
  • Trophoblastic Tumor, Placental Site / drug therapy*
  • Trophoblastic Tumor, Placental Site / secondary*
  • Uterine Neoplasms / drug therapy*
  • Uterine Neoplasms / pathology*
  • Vincristine / therapeutic use

Substances

  • Dactinomycin
  • Vincristine
  • Etoposide
  • Cyclophosphamide
  • Methotrexate